| Dr Angelita Rivera-saez, PSY D | |
|
Calle Acuarela A-3, Marginal Ave. Martinez Nadal, Guaynabo, PR 00969-0072 | |
| (787) 226-8829 | |
| Not Available |
| Full Name | Dr Angelita Rivera-saez |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 13 Years |
| Location | Calle Acuarela A-3, Guaynabo, Puerto Rico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043523822 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 4184 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Angelita Rivera-saez, PSY D Po Box 361366, San Juan, PR 00936-1366 Ph: (787) 429-9864 | Dr Angelita Rivera-saez, PSY D Calle Acuarela A-3, Marginal Ave. Martinez Nadal, Guaynabo, PR 00969-0072 Ph: (787) 226-8829 |
News Archive
RNAi-based therapeutics company Benitec Biopharma Limited today announced the selection of the University of California, San Diego, Health Sciences as the second site for its upcoming phase I/II first-in-man trial for TT-034 in Hepatitis C infections.
Epilepsy affects 50 million people worldwide, but in a third of these cases, medication cannot keep seizures from occurring. One solution is to shoot a short pulse of electricity to the brain to stamp out the seizure just as it begins to erupt. But brain implants designed to do this have run into a stubborn problem: too many false alarms, triggering unneeded treatment. To solve this, Johns Hopkins biomedical engineers have devised new seizure detection software that, in early testing, significantly cuts the number of unneeded pulses of current that an epilepsy patient would receive.
Older adults and those with underlying medical conditions are at risk of experiencing severe coronavirus disease (COVID-19). Younger people appeared to experience only mild illness, but doctors warn that the viral infection may cause sudden strokes.
The Food and Drug Administration (FDA) has approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).
Ryogen and OriGene Technologies have announced today that they have entered into a nonexclusive license agreement whereby OriGene has licensed from Ryogen the patent directed to the clinically important Aminopeptidase P gene.
› Verified 1 days ago
Dr. Aida N Girod Solivan, PSY.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2050 Carr.8177, Apto.501, Guaynabo, PR 00969 Phone: 787-605-0114 Fax: 787-731-3275 | |
Miss Gladys J Concepcion, Psychologist Medicare: Not Enrolled in Medicare Practice Location: Parque San Patricio, Calle Topacio B2, Guaynabo, PR 00968 Phone: 787-649-7850 | |
Ms. Giasselle A Limery-nieves, Psychologist Medicare: Not Enrolled in Medicare Practice Location: Carr. 833 Km. 12.2 Calle Ficus A1 Santa Rosa Iii, Guaynabo, PR 00969 Phone: 787-435-2321 | |
Ms. Nydia J Scalley, M.S Psychologist Medicare: Not Enrolled in Medicare Practice Location: A35 Calle Humacao, Villa Avila, Guaynabo, PR 00969 Phone: 787-759-9595 Fax: 787-767-4798 | |
Mrs. Dianiselle Torres, M.A. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 469 Ave Esmeralda, 141 Cond. Plaza Esmeralda, Guaynabo, PR 00969 Phone: 787-203-8247 Fax: 787-998-4355 | |
Darice Orobitg, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 140 Ave Las Cumbres, Guaynabo Medical Mall Suite 201, Guaynabo, PR 00969 Phone: 787-412-8365 |